EUSA Pharma Mergers and Acquisitions Summary

Life ScienceCompany

EUSA Pharma has acquired 2 companies of its own, including 1 in the last 5 years.

EUSA Pharma’s largest acquisition to date was in 2018, when it acquired SYLVANT for $115M. EUSA Pharma has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to EUSA Pharma’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 2

EUSA Pharma, Inc.

1717 Langhorne-Newtown Road,
Langhorne, Pennsylvania 19047
United States,

EUSA Pharma, Inc., is a trans-Atlantic specialty pharmaceutical company focused on oncology and critical care. EUSA intends to build a portfolio of products that are on the market or in late-stage clinical trials through acquisitions and in-licensing. The company has a sales and marketing organization and commercial infrastructure in the US and all major European countries.

M&A Summary

Buy vs Sell

Year ≤ '17 '18 '19 '20 '21 '22 T
Buy (0.2/yr) # 1 1 - - - - 2
vol $115M $115M
Sell (0.0/yr) # - - - - - - 0

Most Recent M&A

Company Date Value Type
SYLVANT 2018-07-18 115M USD Divestiture
, United States ·
Apeiron Biologics AG - Isqette (Dinutuximab Beta) 2016-10-04 - Divestiture
Langhorne, Pennsylvania
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 115M (100%) - -
Total 2 $115M - -

By Geo

State/Country Buy Value Sell Value
United States 2 115M - -
  Pennsylvania 1 - - -
Total 2 $115M - -

Deal Values

buy # Total
$100M to $1B 1 $115M
$115M (2018-07-18)

M&A Connections

Acquired from
2 (100%)

 Subscribe to unlock this and 185,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.4K Private Equity Firms
  • 176K M&A Transactions
  • 181K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 66K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.